P450 Vaccination strategies in Inflammatory Bowel Disease patients: perspective of physicians and patients

Abstract Background Despite the existence of specific recommendations, patients with Inflammatory Bowel Disease (IBD) have shown low immunization rates. The aim this study was to evaluate management vaccines in clinical practice IBD from perspective physicians and patients. Methods An online anonymous survey sent 8000 a national patient association (ACCU-Spain) 1000 members Spanish Working Group (GETECCU). Three invitations were between October-December 2020. Forty questions jointly designed by ACCU GETECCU two different surveys for Descriptive analyses performed, comparing physician’s patient’s responses standard statistical Results 144 1302 responded (overall mean age 43 years (SD 9.5). 65% managed more than 200 80% had >5 experience. Most (99%) concerned about their practice, 63% them considered very important. Only 3.5% recommended live immunosuppressive treatments. One third did not recommend HPV vaccine. In spite 69% recommending influenza vaccine during pregnancy, only 7.2% pregnant indicated that they received advice on vaccination pregnancy (p<0.001). 16.6% first year life children born mothers exposed biologics, 4.4% inactive vaccines. Moreover, treated biologics well trained vaccines, compared those other drugs. Table 1 summarizes Conclusion Deficiencies knowledge regarding can be frequent. is different, perceiving recommendations related recommended.